Pharmaceuticals (42) | Share Agreements (42)
Browse by Company
Recent Contracts
-
Description of Share Capital
(Jazz Pharmaceuticals plc, Filed With SEC on February 23, 2021)
-
First Amendment to Share Purchase Agreement, dated February 1, 2021, by and between EyePoint Pharmaceuticals, Inc. and Ocumension Therapeutics
(EyePoint Pharmaceuticals, Inc., Filed With SEC on February 3, 2021)
-
Share Purchase Agreement, dated December 31, 2020, by and between EyePoint Pharmaceuticals, Inc. and Ocumension Therapeutics
(EyePoint Pharmaceuticals, Inc., Filed With SEC on January 4, 2021)
-
Share Purchase Agreement, dated as of December 18, 2020, by and among EyeGate Pharmaceuticals, Inc. and the Sellers listed therein
(EYEGATE PHARMACEUTICALS INC, Filed With SEC on December 21, 2020)
-
Share Cancellation Agreement dated November 16, 2020
(QUANTA INC, Filed With SEC on November 18, 2020)
-
Form of Class A Ordinary Share Certificate
(Royalty Pharma plc, Filed With SEC on October 13, 2020)
-
Form of Share Purchase Agreement
(TITAN PHARMACEUTICALS INC, Filed With SEC on September 25, 2020)
-
Share Issuance Agreement pursuant to License Agreement with Yuhan Corporation
(Processa Pharmaceuticals, Inc., Filed With SEC on September 17, 2020)
-
Adicet Therapeutics, Inc. Share Option Plan (2014)
(resTORbio, Inc., Filed With SEC on September 16, 2020)
-
Amendment No. 1 to the Adicet Therapeutics, Inc. Share Option Plan (2014)
(resTORbio, Inc., Filed With SEC on September 16, 2020)
